# Altimmune, Inc.: Form 8-K, filed Oct 3, 2025

- Company: [Altimmune, Inc.](/companies/alt.md) (CIK 1326190)
- Form: 8-K
- Filed: 2025-10-03
- Accepted by EDGAR: Oct 3, 2025, 16:02 ET
- Period: 2025-10-01
- Accession: 0001326190-25-000053
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326190/000132619025000053/alt-20251001x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326190/000132619025000053/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326190/000132619025000053/alt-20251001x8k.htm

Filed Oct 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001326190-25-000053. Last ingested by Listed: Nov 14, 2026, 20:51 ET. No prices; not investment advice.
